Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests
Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…
Cupping, leeching and other ancient healing methods welcomed in Turkish hospitals
By Ezgi Erkoyun ISTANBUL (Reuters) -In a brightly lit treatment room at a private hospital in Istanbul, doctor…
Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer
Head and neck cancer remains a major global health challenge, ranking among the six most common cancers worldwide…